Академический Документы
Профессиональный Документы
Культура Документы
responsibilities
Brand Name: Inhibits activation of Used for the Acquired Assess
Cyklokapron plasminogen treatment of defective color baseline BP
severe vision, since this and pulse
localized prohibits before starting
Generic Name: bleeding measuring one IV.
Tranexamic Acid secondary to endpoint that
hyperfibrinolysi should be Anticipate
s, including followed as a reduced
Dosage: epistaxis. measure of dosage in
500mg toxicity. patients with
Used for the impaired renal
Frequency: management of Subarachnoid function.
Every 8hours haemophilic hemorrhage.
patients Anecdotal Observe
experience patient with
Route: Used for the indicates the sign and
PO treatment of cerebral edema symptoms of
hereditary and cerebral thrombosis.
angioedema infarction maybe
cause by
CYKLOKAPRON
in such patients.
Active intra
vascular clotting